Scientific Programme
 |
09:15 - 10:45 Oral Session 6 - Sexual dysfunction
| Overview D.G. Hatzichristou, Thessaloniki (GR) |
| 288: Maxi-K gene transfer with a smooth muscle specific promoter enhances erectile function and sexual behaviour in atherosclerotic cynomolgous monkeys G.C. Christ, Winston Salem (US) |
| 289: Micro array analysis of the impact of sildenafil treatment on gene expression in the rat cavernous nerve injury model A. Müller, New York (US) |
| 290: Aspects of sexual satisfaction: A factor analytic and multivariate linear regression approach in 4174 men with erectile dysfunction A.R. Fugl-Meyer, Uppsala (SE) |
| 291: Is there an association between late onset hypogonadism (LOH) and vascular risk factors? Results from the VITA-study A. Ponholzer, Vienna (AT) |
| 292: Diet-induced weight loss vs. exercise-induced weight loss: Is there an effect on erectile dysfunction in obese men? M. Mathers, Remscheid (DE) |
| 293: Time to continence recovery is an independent predictor of erectile function recovery after bilateral nerve sparing radical prostatectomy A. Gallina, Milan (IT) |
| 294: Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: A double blind placebo-controlled and randomised study M.R. Safarinejad, Tehran (IR) |
| 295: Salvage of sildenafil failures with bremelanotide: A randomised, double-blind, placebo-controlled study M.R. Safarinejad, Tehran (IR) |
| Summary F. Fusco, Naples (IT) |